Dr Fares Qeadan, the paper’s primary author, explains to Popular Science that opioids and alcohol were chosen for the study ...

Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

Ozempic could cut binge drinking and opioid abuse, major research suggests. A US study of more than 800,000 people with a ...

A study suggests that weight loss medications like Ozempic may help reduce the risk of overdose and alcohol intoxication in ...

These medications have been associated with a 40 percent reduction in opioid overdose and 50 percent lower rate of alcohol intoxication.

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) given to adolescents with obesity was associated with a one-third ...

Researchers found that the study cohort had a significantly lower risk for suicidal ideation or attempts during 12 months of follow-up.

Recent studies have shown that pharmacologic weight loss with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and ...

Researchers find that Semaglutide improves cognitive function and reduces amyloid and tau pathology in Alzheimer's disease ...

Researchers reveal the importance of personalized communication and side effect management in improving outcomes for patients ...

A weight-loss drug more effective than Ozempic and Wegovy has recently been approved. Here’s how it works and how it compares ...

Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...